Notice of Q1 2021 Trading Update
Source: RNS
14 January 2021
UDG Healthcare plc
Notice of Q1 2021 Trading Update
UDG Healthcare plc ("UDG Healthcare" or "Group"), a leading international healthcare services provider, will issue a trading update for the first quarter to 31 December 2020 at 7.00 a.m. (GMT) on Tuesday, 26 January 2021.
The Company will host a conference call for investors and analysts at 9.00am (GMT) on Tuesday, 26 January 2021 to discuss the statement.
Date: 26 January 2021
Time: Conference call commencing at 9.00am. Please dial in at 8.45am to ensure a timely start to the briefing
Conference Call Registration Link: https://secure.emincote.com/client/udghealthcare/udg007/vip_connect
It is suggested participants register in advance to obtain their unique dial-in details.
For further information, please contact:
Keith Byrne
Head of Investor Relations, Strategy & Corporate Communications
UDG Healthcare plc
Tel: +353-1-468-9000
Lisa Kavanagh / Eavan Gannon / Ella Morris
Powerscourt
Tel: +44-207-250-1446
Email: udghealthcare@powerscourt-group.com
About UDG Healthcare plc:
UDG Healthcare plc (LON: UDG) is a FTSE 250 global leader in the healthcare advisory, communications, commercial, clinical and packaging services industries. UDG employs 9,000 people across operations in 29 countries, delivering services in over 50 countries.
Operating across two divisions, Ashfield and Sharp, UDG provides outsourced services which enable over 300 healthcare companies from large pharmaceutical to small biotech to bring their products to market.
Ashfield is a global leader in commercialisation services for the pharmaceutical and healthcare industry, operating across three business areas: Advisory, Communications and Commercial & Clinical. The division focuses on supporting patients to access and adhere to their medications and educating and communicating effectively with healthcare professionals and patients on these products at all stages of the product life cycle. Ashfield provides strategic consulting, advisory services, patient solutions, scientific and creative communications, PR, on-demand advertising services, field and contact centre sales teams, and medical information and event management services.
Sharp is a global leader in contract commercial packaging, clinical, manufacturing and technology services for the pharmaceutical and biotechnology industries, operating from eight state-of-the-art facilities in the US and Europe.
For more information, please go to: www.udghealthcare.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
